Clinical Trial

Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate efficacy and safety of KHK4951 eye drops in patients with nAMD.
Protocol Amendment History 19 amendments
This ClinicalTrials.gov record has been amended 19 times since 2023-10-31; most recent amendment 2025-10-29.
Status change: Recruiting → Active, Not Recruiting 2025-10-29
Status change: Not Yet Recruiting → Recruiting 2024-02-06
Trial Details
NCT Number NCT06116890
Lead Sponsor Kyowa Kirin Co., Ltd.
Conditions Neovascular Age-Related Macular Degeneration (nAMD)
Enrollment 180 participants
Start Date 2024-01-31
Primary Completion 2026-08-31 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-10-30